W
WAVEMAN · COMPANY
BNR · Burning Rock Biotech Ltd
> Ask across nine datasets ⌘K
LIVE
TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475
← ALL COMPANIES

BNR

Burning Rock Biotech Ltd
HEALTHCARE SERVICES · SERVICES-MEDICAL LABORATORIES · CIK 0001792267
SEC FILINGS☆ WATCH
INSIDER NET · 180D
$11.6M
open-market buys minus sells, Form 4 codes P and S
INSIDER BUYERS · 180D
1
CONGRESS BUYERS · 1Y
0
FUNDS ADDED · QTR
10
13F, latest reported quarter
REVENUE GROWTH
+9.2%
XBRL, annual
NET MARGIN
-10.3%
SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST
INSIDERS
net +$11.6M over 180 days
+$6.2M over 90 days
more than 95% of Healthcare Services
CONGRESS
no member of Congress has reported trading it
FUNDS
10 funds added or opened last quarter
below 93% of Healthcare Services
REVENUE
+9.2% year over year
below 56% of Healthcare Services
MARGIN
-10.3% net margin
below 75% of Healthcare Services
BUYBACKS
no share repurchases reported
SHORT
6.7 days to cover · settled 2026-07-31
The year, with the filings on it
Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail
TOTAL 12M RETURN +52.9%
+52.9%12M
-10%+134%+279%+424%2025-092025-102025-122026-032026-052026-072026-09 2026-03-31 · Han Yusheng bought $5.5M2026-06-24 · Han Yusheng bought $2.0M2026-06-12 · Han Yusheng bought $1.9M2026-06-16 · Han Yusheng bought $1,000.0K2026-06-22 · Han Yusheng bought $779.7K2026-06-11 · Han Yusheng bought $216.4K2026-06-26 · Han Yusheng bought $199.1K2026-06-23 · Han Yusheng bought $44.9K
INSIDER BUY
INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY
Live price
Daily candles from TradingView, on their licence — no filings are marked on this one
WHY THIS NAME IS ON THE DESK
Insiders are net buyers of their own stock.
The record shows a net $11.6M bought by insiders over 180 days, 10 funds added last quarter. Every figure is a federal filing, dated the day it became public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector from the SEC's own SIC classification
NTRACSTLPGNYHIMSWGSPRVATDOCAVAHGHADUSSERABDSX
Insider transactions
Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, Burning Rock Biotech Ltd insiders bought a net $11.6M of stock across 8 Form 4 purchases and sales, with 1 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-05.

INSIDER
FILED
SHARES
VALUE
Han Yusheng
Director
BUY
2026-06-26
24,900.0
$199.1K
Han Yusheng
Director
BUY
2026-06-24
250,000.0
$2.0M
Han Yusheng
Director
BUY
2026-06-23
5,990.0
$44.9K
Han Yusheng
Director
BUY
2026-06-22
104,650.0
$779.7K
Han Yusheng
Director
BUY
2026-06-16
111,110.0
$1,000.0K
8 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 3 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders
13F · holdings as of the latest quarter funds have reported
Kynam Capital Management, LP
1,238,563.0 sh
$10.5M
CRCM LP
423,994.0 sh
$3.5M
RENAISSANCE TECHNOLOGIES LLC
52,838.0 sh
$442.3K
MORGAN STANLEY
43,594.0 sh
$364.9K
Amova Asset Management Americas, Inc.
29,724.0 sh
$257.7K
SCHEDULE 13D/G
No 5%+ ownership filings
Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.
FORM 144
No planned-sale notices
No insider has notified an intent to sell. This is the panel to watch after a run-up.
Fund concentration
N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show
Even Herd Long Short ETF
$40.0K POSITION · AS OF 2026-03-31
0.1%
Invesco Golden Dragon China ETF
$75.8K POSITION · AS OF 2026-04-30
0.1%
Emerging Markets Social Core Equity Portfolio
$15.7K POSITION · AS OF 2026-04-30
0.0%
THE EMERGING MARKETS SMALL CAP SERIES
$15.6K POSITION · AS OF 2026-04-30
0.0%
Fidelity Nasdaq Composite Index Fund
$83.7K POSITION · AS OF 2026-02-28
0.0%
World ex U.S. Core Equity Portfolio
$10.5K POSITION · AS OF 2026-04-30
0.0%
SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK
Fundamentals
Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all
2025-122024-122023-122022-12
REVENUE$539.6M$515.8M$537.4M$563.2M
GROSS PROFIT$402.9M$362.4M$363.2M$380.0M
OPERATING INCOME$-54.8M$-357.6M$-669.3M$-980.4M
NET INCOME$-55.3M$-346.6M$-653.7M$-971.2M
OPERATING CASH FLOW$-28.4M$-92.3M$-255.8M$-456.8M
CASH$478.4M$519.8M$615.1M$905.5M
SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-05 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE
W WAVEMAN

Public filings, honestly analyzed. Official US government sources in one desk — every figure carries the date it was filed, and the methodology is published, backtest included.

SEC FORM 4FORM 13F 13D/GFORM 144XBRL STOCK ACTCONTRACTSFEC CFPBNRC
PRODUCT
DeskBacktester CompaniesAccount
SUPPORT
FAQMethodology Contact
LEGAL
TermsPrivacy Accessibility
© 2026 WAVEMAN · SOURCE: SEC EDGAR & OFFICIAL GOVERNMENT DATA · NOT INVESTMENT ADVICE · CHART BY TRADINGVIEW · UPDATED 2026-09-05 ALL SYSTEMS LIVE FOR MACHINES →